Among the vaccines have been developed thus far against SARS-CoV-2, the mRNA-based
ones have demonstrated more promising results regarding both safety and efficacy. Two …

Messenger RNA (mRNA) vaccines are promising alternatives to conventional vaccines in
many aspects. We previously developed a lipopolyplex (LPP)‐based mRNA vaccine …

Messenger RNA (mRNA) vaccines have demonstrated efficacy against Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) in humans. mRNA technology holds …

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
was identified in December of 2019 and is responsible for millions of infections and deaths …

Abstract mRNA-based drugs have tremendous potential as clinical treatments, however, a
major challenge in realizing this drug class will promise to develop methods for safely …

mRNA vaccines have been demonstrated as a powerful alternative to traditional
conventional vaccines because of their high potency, safety and efficacy, capacity for rapid …

mRNA vaccines have recently received significant attention due to their role in combating
the SARS-CoV-2 pandemic. As a platform, mRNA vaccines have been shown to elicit strong …

The COVID-19 pandemic demonstrates the ongoing threat of pandemics caused by novel,
previously unrecognized, or mutated pathogens with high transmissibility. Currently, vaccine …

Vaccines utilizing modified messenger RNA (mRNA) technology have shown robust
protective efficacy against SARS-CoV-2 in humans. As the virus continues to evolve in both …

The creation of safe and effective vaccines that induce potent cellular and humoral immune
responses against SARS-CoV-2 is urgently needed to end the global COVID-19 epidemic …